BR0116253A - método de combinação para tratar infecções virais - Google Patents

método de combinação para tratar infecções virais

Info

Publication number
BR0116253A
BR0116253A BRPI0116253-5A BR0116253A BR0116253A BR 0116253 A BR0116253 A BR 0116253A BR 0116253 A BR0116253 A BR 0116253A BR 0116253 A BR0116253 A BR 0116253A
Authority
BR
Brazil
Prior art keywords
viral infections
treat viral
combination method
polypeptide
pharmaceutically acceptable
Prior art date
Application number
BRPI0116253-5A
Other languages
English (en)
Portuguese (pt)
Inventor
Bahige M Baroudy
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of BR0116253A publication Critical patent/BR0116253A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Peptides Or Proteins (AREA)
BRPI0116253-5A 2000-12-19 2001-12-17 método de combinação para tratar infecções virais BR0116253A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25665700P 2000-12-19 2000-12-19
PCT/US2001/048802 WO2002056902A2 (en) 2000-12-19 2001-12-17 Ccr5 antagonist and dp-178 polypeptide for treating viral infections

Publications (1)

Publication Number Publication Date
BR0116253A true BR0116253A (pt) 2006-05-02

Family

ID=22973061

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0116253-5A BR0116253A (pt) 2000-12-19 2001-12-17 método de combinação para tratar infecções virais

Country Status (12)

Country Link
US (1) US20050065319A1 (cg-RX-API-DMAC10.html)
EP (1) EP1385534A2 (cg-RX-API-DMAC10.html)
JP (1) JP2005500981A (cg-RX-API-DMAC10.html)
CN (1) CN1481251A (cg-RX-API-DMAC10.html)
AR (1) AR031931A1 (cg-RX-API-DMAC10.html)
BR (1) BR0116253A (cg-RX-API-DMAC10.html)
CA (1) CA2431919A1 (cg-RX-API-DMAC10.html)
HU (1) HUP0302241A3 (cg-RX-API-DMAC10.html)
MX (1) MXPA03005526A (cg-RX-API-DMAC10.html)
NO (1) NO20032769L (cg-RX-API-DMAC10.html)
WO (1) WO2002056902A2 (cg-RX-API-DMAC10.html)
ZA (1) ZA200304560B (cg-RX-API-DMAC10.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2400553A (en) * 2003-04-14 2004-10-20 Cipla Ltd Antiviral pharmaceutical combination of lamivudine, stavudine and efavirenz, or derivatives thereof
RU2353357C2 (ru) * 2003-05-16 2009-04-27 Юниверсити Оф Мэрилэнд Байотекнолоджи Инститьют Композиции для супрессии экспрессии ccr5 и способы их применения
WO2006055638A2 (en) 2004-11-17 2006-05-26 Abgenix, Inc. Fully human monoclonal antibodies to il-13
JP2009517474A (ja) * 2005-11-30 2009-04-30 シェーリング コーポレイション Ccr5拮抗剤およびcxcr4拮抗剤の組み合わせを含む組成物
WO2007065007A2 (en) * 2005-12-01 2007-06-07 Government Of The U.S.A., As Repersented By The Secretary, Dept. Of Health And Human Services Treatment of viral infections
EP1886696A1 (en) * 2006-08-03 2008-02-13 Endotis Pharma Conjugates of antithrombin binding oligosaccharide derivatives and therapeutic proteins
CN104039815A (zh) * 2012-02-28 2014-09-10 中国人民解放军军事医学科学院毒物药物研究所 用于抑制hiv的多肽及其作用靶点
US11629196B2 (en) 2020-04-27 2023-04-18 Incelldx, Inc. Method of treating SARS-CoV-2-associated hypercytokinemia by administering a human monoclonal antibody (PRO-140) that inhibits CCR5/CCL5 binding interactions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5464933A (en) * 1993-06-07 1995-11-07 Duke University Synthetic peptide inhibitors of HIV transmission
CN1192688A (zh) * 1995-06-07 1998-09-09 特莱默里斯公司 联合疗法治疗hiv和其它病毒性感染
US6281331B1 (en) * 1998-03-23 2001-08-28 Trimeris, Inc. Methods and compositions for peptide synthesis
US6689765B2 (en) * 1999-05-04 2004-02-10 Schering Corporation Piperazine derivatives useful as CCR5 antagonists
US6391865B1 (en) * 1999-05-04 2002-05-21 Schering Corporation Piperazine derivatives useful as CCR5 antagonists
PL203117B1 (pl) * 1999-05-04 2009-08-31 Schering Corp Piperydynopiperydynowa pochodna użyteczna jako antagonista CCR5, zawierająca ją kompozycja farmaceutyczna i jej zastosowanie
US6387930B1 (en) * 1999-05-04 2002-05-14 Schering Corporation Piperidine derivatives useful as CCR5 antagonists
WO2000066141A2 (en) * 1999-05-04 2000-11-09 Schering Corporation Pegylated interferon alfa-ccr5 antagonist combination hiv therapy

Also Published As

Publication number Publication date
EP1385534A2 (en) 2004-02-04
WO2002056902A2 (en) 2002-07-25
WO2002056902A3 (en) 2002-12-05
HUP0302241A3 (en) 2005-06-28
JP2005500981A (ja) 2005-01-13
MXPA03005526A (es) 2003-10-06
ZA200304560B (en) 2005-07-27
NO20032769D0 (no) 2003-06-18
US20050065319A1 (en) 2005-03-24
CA2431919A1 (en) 2002-07-25
CN1481251A (zh) 2004-03-10
NO20032769L (no) 2003-08-18
HUP0302241A2 (hu) 2003-11-28
AR031931A1 (es) 2003-10-08

Similar Documents

Publication Publication Date Title
BR0113200A (pt) Combinação terapêutica
BR0115166A (pt) Combinações de drogas (por exemplo, cloropromazina e pentamidina) para o tratamento de distúrbios neoplásticos
PT1066036E (pt) Agentes com actividade relacionada com serotonina para o tratamento da apneia do sono
BRPI0507628A (pt) composto ou sal farmaceuticamente aceitável do mesmo, método de tratamento de uma infecção viral em um ser humano, uso de um composto composição farmacêutica, e, processo para a preparação de um composto
ATE347376T1 (de) Behandlung von allergien
DK0680326T3 (da) Farmaceutisk formulering af nikotinafhængighed.
NO20052420L (no) Farmakologisk behandling av sovnapn±.
ATE447403T1 (de) Cannabinoiden zur behandlung von während des schlafens auftretenden atmungsstörungen
AU1794601A (en) Prevention and treatment of pulmonary bacterial infection or symptomatic pulmonary exposure to endotoxin by inhalation of antiendotoxin drugs
MA27059A1 (fr) Azithromycine en dose unique
EP0934065A4 (en) PHARMACEUTICAL COMPOSITION
ATE400564T1 (de) Ppar alpha selektive verbindungen zur behandlung von dyslipidämie und anderen lipidstörungen
ATE208200T1 (de) Transdermales therapeutisches system (tts) zur verabreichung von testosteron
WO2002056902A3 (en) Ccr5 antagonist and dp-178 polypeptide for treating viral infections
MXPA04001912A (es) Aminobenzofenonas novedosas.
NO20052999L (no) Ny synergistisk kombinasjon omfattende roflumilast og formoterol
BR9712033A (pt) Composição farmacêutica para tratamento de doenças virais.
PT1178819E (pt) Glutationa-redutase para a terapia e profilaxia da sida
BR0011845A (pt) Complexo farmacêutico
BR0209985A (pt) Composto e método para o tratamento de um paciente
DK0651648T3 (da) Farmaceutisk præparat indeholdende IL-6. Anvendelse deraf til behandling af konsumptiv trombo-hæmoragisk sygdom
DE60306503D1 (de) Statin-therapie zur verbesserung der aufrechterhaltung der kognitiven funktion
ATE233745T1 (de) Arzneistoffe
DE60106890D1 (de) Verwendung von cdp-choline zur behandlung des alkoholentzugsyndroms
DK0692963T3 (da) Anvendelse af terbinafin til terapeutisk behandling af pneumocystose

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: CONFORME ARTIGO 10O DA RESOLUCAO 124/06, CABE SER ARQUIVADO REFERENTE AO NAO RECOLHIMENTO DA 6A, 7A, 8A, 9A E 10A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2144 DE 07/02/2012.